The current status of lipoprotein (a) in pregnancy: a literature review

Angela E Fanshawe1, Michael Ibrahim

  • 1National Heart and Lung Institute, Imperial College London, UK.

Journal of Cardiology
|November 21, 2012
PubMed

Insights

Lipoprotein (a) levels change during pregnancy, impacting maternal and fetal health. Further research is needed to fully understand these changes and their clinical implications in normal and complicated pregnancies.

Area of Science:

  • Reproductive Medicine
  • Cardiovascular Science
  • Biochemistry

Background:

  • Lipoprotein (a) [Lp(a)] is a key blood lipid marker.
  • Lp(a) is linked to coronary heart disease, atherosclerosis, and thrombosis.
  • Pregnancy significantly alters maternal metabolism.

Purpose of the Study:

  • To synthesize and evaluate existing evidence on Lp(a) in pregnancy.
  • To assess the role of Lp(a) in normal and complicated pregnancies.
  • To identify gaps in current research on Lp(a) and pregnancy.

Main Methods:

  • Systematic review of MEDLINE database.
  • Literature search from May 2003 to May 2012.
  • Analysis of 14 studies on Lp(a) profiles in pregnancy.

Main Results:

  • Reviewed studies on normal pregnancy metabolic responses.
  • Analyzed pregnancies with pre-eclampsia and intrauterine growth restriction.
  • Examined the effect of pregnancy complications on Lp(a) levels and outcomes.

Conclusions:

  • Significant data exists on Lp(a) changes during pregnancy.
  • Diverse study designs limit broad conclusions.
  • Key unanswered questions regarding Lp(a) in pregnancy were identified.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
What are Lipids?01:38

What are Lipids?

Overview